Skip to main content
Fig. 4 | Alzheimer's Research & Therapy

Fig. 4

From: Increased levels of the synaptic proteins PSD-95, SNAP-25, and neurogranin in the cerebrospinal fluid of patients with Alzheimer’s disease

Fig. 4

CSF levels of PSD-95 (A) and SNAP-25 (B) in healthy controls (HC) and subjects with AD, non-AD neurodegenerative diseases (NeuroDegen), and other neurological conditions (NeuroCtrl) from cohort II. PSD-95 (C) and SNAP-25 (D) levels in HC and AD subjects stratified by cognitive status. Asymptomatic refers to cognitively unimpaired subjects with positive CSF AD biomarkers. Solid green lines represent the median of the groups and dotted green lines represent mean

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193